BlackRock Institutional Trust’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.93M | Buy |
380,570
+14,152
| +4% | +$109K | ﹤0.01% | 2917 |
|
|
2016
Q3 | $4.19M | Buy |
366,418
+83,935
| +30% | +$959K | ﹤0.01% | 2765 |
|
|
2016
Q2 | $3.48M | Buy |
282,483
+17,309
| +7% | +$213K | ﹤0.01% | 2830 |
|
|
2016
Q1 | $2.68M | Buy |
265,174
+4,335
| +2% | +$43.8K | ﹤0.01% | 2913 |
|
|
2015
Q4 | $5.88M | Buy |
260,839
+36,555
| +16% | +$824K | ﹤0.01% | 2628 |
|
|
2015
Q3 | $3.72M | Buy |
224,284
+86,537
| +63% | +$1.44M | ﹤0.01% | 2845 |
|
|
2015
Q2 | $3.1M | Buy |
137,747
+9,527
| +7% | +$214K | ﹤0.01% | 2941 |
|
|
2015
Q1 | $3.31M | Buy |
128,220
+3,257
| +3% | +$84K | ﹤0.01% | 2905 |
|
|
2014
Q4 | $2.72M | Sell |
124,963
-2,552
| -2% | -$55.5K | ﹤0.01% | 2969 |
|
|
2014
Q3 | $2.41M | Sell |
127,515
-47,168
| -27% | -$893K | ﹤0.01% | 2988 |
|
|
2014
Q2 | $4.07M | Buy |
174,683
+98,533
| +129% | +$2.3M | ﹤0.01% | 2873 |
|
|
2014
Q1 | $2.56M | Sell |
76,150
-11,567
| -13% | -$389K | ﹤0.01% | 3052 |
|
|
2013
Q4 | $2.59M | Sell |
87,717
-75,237
| -46% | -$2.22M | ﹤0.01% | 3055 |
|
|
2013
Q3 | $2.5M | Buy |
+162,954
| New | +$2.5M | ﹤0.01% | 3016 |
|